Neoadjuvant chemoradiotherapy for resectable oesophageal and gastro-oesophageal junction cancer--do we need another randomised trial?
暂无分享,去创建一个
A. Maraveyas | A. Bateman | M. Hingorani | S. Dixit | R. Roy | T. Crosby | A. Bateman
[1] 闵先军,et al. Oesophageal cancer , 2011 .
[2] J. V. van Sandick,et al. Systematic review of the benefits and risks of neoadjuvant chemoradiation for oesophageal cancer , 2010, The British journal of surgery.
[3] E. Steyerberg,et al. Effect of preoperative concurrent chemoradiotherapy on survival of patients with resectable esophageal or esophagogastric junction cancer: Results from a multicenter randomized phase III study. , 2010 .
[4] R. Malthaner,et al. Preoperative or postoperative therapy for resectable oesophageal cancer: an updated practice guideline. , 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).
[5] J. Hainsworth,et al. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] M. Posner,et al. Neoadjuvant strategies for the treatment of locally advanced esophageal cancer , 2010, Journal of surgical oncology.
[7] N. Rizk,et al. Randomized clinical trials in esophageal carcinoma. , 2010, Surgical oncology clinics of North America.
[8] P. Schlag,et al. Neoadjuvant chemotherapy versus surgery alone for locally advanced adenocarcinoma of the stomach and cardia: Randomized EORTC phase III trial #40954. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] Hong Zhu,et al. Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis. , 2009, World journal of gastroenterology.
[10] W. Allum,et al. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] C. Belka,et al. Evidence-based radiation oncology: oesophagus. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[12] T. Crosby,et al. The management of locally advanced carcinoma of the oesophagus - SCOPE for improvement? , 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).
[13] M. Stuschke,et al. Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] E. Steyerberg,et al. Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS) , 2008, BMC surgery.
[15] S. Force,et al. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer. , 2008, The Annals of thoracic surgery.
[16] D. Sugarbaker,et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] G. Nieuwenhuijzen,et al. A Highly Active and Tolerable Neoadjuvant Regimen Combining Paclitaxel, Carboplatin, 5-FU, and Radiation Therapy in Patients with Stage II and III Esophageal Cancer , 2007, Annals of Surgical Oncology.
[18] L. Kleinberg,et al. Chemoradiation in the management of esophageal cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] J. Ajani,et al. Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] G. Wagenius,et al. A randomized trial of chemoradiotherapy versus surgery alone in patients with resectable esophageal cancer , 2007 .
[21] J. Pignon,et al. Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial , 2007 .
[22] B. Manns,et al. Defining the optimal treatment of locally advanced esophageal cancer: a systematic review and decision analysis. , 2007, The Annals of thoracic surgery.
[23] T. Conroy,et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] Val Gebski,et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. , 2007, The Lancet. Oncology.
[25] V. Rusch,et al. American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] N. Boku. Randomized Phase III study of 5-fluorouracil alone versus combination of irinotecan and cisplatin versus S-1 alone in advanced gastric cancer (JCOG9912) , 2007 .
[27] J. Siewert,et al. Are squamous and adenocarcinomas of the esophagus the same disease? , 2007, Seminars in radiation oncology.
[28] C. V. D. van de Velde,et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. , 2006, The New England journal of medicine.
[29] S. DeMeester. Adenocarcinoma of the Esophagus and Cardia: A Review of the Disease and Its Treatment , 2006, Annals of Surgical Oncology.
[30] V. Gebski,et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. , 2005, The Lancet. Oncology.
[31] Hao Wang,et al. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] Nils Lehmann,et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] R. Malthaner,et al. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis , 2004, BMC medicine.
[34] A. Venturi,et al. Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis , 2004, Gut.
[35] J. Lee,et al. A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[36] J. Urschel,et al. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. , 2002, American journal of surgery.
[37] A. Livingstone,et al. Neoadjuvant Treatment for Resectable Cancer of the Esophagus and the Gastroesophageal Junction: A Meta-Analysis of Randomized Clinical Trials , 2003, Annals of Surgical Oncology.
[38] Paul Fockens,et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. , 2002, The New England journal of medicine.
[39] N. Altorki,et al. Three-Field Lymph Node Dissection for Squamous Cell and Adenocarcinoma of the Esophagus , 2002, Annals of surgery.
[40] D. Girling. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial , 2002, The Lancet.
[41] V. Chiarion Sileni,et al. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma , 2001, Cancer.
[42] M. Iannettoni,et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[43] M. Iannettoni,et al. Transhiatal esophagectomy: clinical experience and refinements. , 1999, Annals of surgery.
[44] J. Ajani,et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. , 1998, The New England journal of medicine.
[45] K. Chu,et al. Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. , 1997, The Journal of thoracic and cardiovascular surgery.
[46] J. Bosset,et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. , 1997, The New England journal of medicine.
[47] L. Karnell,et al. National Cancer Data Base report on esophageal carcinoma , 1996, Cancer.
[48] T. Walsh,et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. , 1996, The New England journal of medicine.
[49] P. Puttisak,et al. A prospective study of combined therapy in esophageal cancer. , 1994, Hepato-gastroenterology.
[50] A. Geater,et al. Induction chemotherapy in the treatment of patients with carcinoma of the esophagus , 1994, Journal of surgical oncology.